Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$486.62 USD

486.62
740,884

+1.86 (0.38%)

Updated Oct 2, 2024 04:00 PM ET

After-Market: $487.17 +0.55 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Abiomed Hits New 52-Week High: 3 Factors Driving the Stock

Abiomed (ABMD) recently reported strong preliminary third-quarter fiscal 2018 results.

    Zacks.com highlights: Caterpillar, Crocs, Pioneer Natural Resources, Legg Mason and Intuitive Surgical

    Zacks.com highlights: Caterpillar, Crocs, Pioneer Natural Resources, Legg Mason and Intuitive Surgical

      Becton, Dickinson Completes Enrollment in Lutonix DCB Trial

      Becton, Dickinson's (BDX) focus in the Balloon-Angioplasty space is expected to lend the company a competitive edge in the niche MedTech markets.

        Medtronic's FDA Nod for Riptide Aspiration System Boosts RTG

        Medtronic (MDT) makes efforts to boost RTG business.

          Becton, Dickinson Hits a 52-Week High: What's Driving It?

          Becton, Dickinson (BDX) rides on favorable regulatory developments and strategic acquisitions.

            5 Top Stocks Powered by Beat Potential This Earnings Season

            Bet on five stocks that are likely to outdo earnings estimates.

              Medtronic (MDT) Wins FDA Nod for New Clinician Programmer

              Medtronic's (MDT) latest FDA nod likely to boost Pain Therapies division.

                5 Reasons Why You Should Offload Wright Medical Stock Now

                Foreign currency fluctuations and pricing pressure continue to be major headwinds for Wright Medical Group (WMGI).

                  5 Reasons Why McKesson Deserves a Place in Your Portfolio

                  McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.

                    Will Intuitive Surgical (ISRG) Disappoint in Q4 Earnings?

                    Intuitive Surgical (ISRG) is expected to witness growth across da Vinci Surgical and Service segments. Instruments and accessories revenues are also expected to increase year over year.

                      Medtronic's ITB Therapy Superior to CMM for PSS Reduction

                      Medtronic (MDT) consistently tries efforts to boost Pain Therapies division, part of the Restorative Therapies Group.

                        Myriad Genetics Fortifies Molecular Diagnostics With FDA Nod

                        Myriad Genetics (MYGN) has been leaving no stone unturned to boost the uptake of BRACAnalysis CDx test and strengthen the Molecular Diagnostics portfolio.

                          QIAGEN Partners DiaSorin, Boosts Molecular Diagnostics Arm

                          QIAGEN (QGEN) continues to adopt initiatives to strengthen Molecular Diagnostics business.

                            Express Scripts 90-Day Analysis of Opioid Management Positive

                            Express Scripts (ESRX) addresses the national opioid epidemic by reducing excessive and improper opioid use.

                              Henry Schein (HSIC) Buys ABASE, Expands in Animal Health

                              Henry Schein (HSIC) forges ahead with deals to strengthen the Global Animal Health business.

                                Baxter (BAX) Launches Arisure Closed System Transfer Device

                                Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.

                                  Abbott's (ABT) Diabetes Care Unit Strong on FreeStyle Libre

                                  Abbott (ABT) forges ahead with initiatives to boost diabetes care. The latest CMS recognition will widen customer base for FreeStyle Libre glucose monitoring system.

                                    Integra LifeSciences Estimates Strong Revenue Figures for Q4

                                    Integra LifeSciences (IART) sees strong organic growth in the company's Specialty Surgical Solutions as well as Orthopedics and Tissue Technologies businesses.

                                      Intuitive Surgical (ISRG) Upbeat on Q4 & 2017 Sales Results

                                      Intuitive Surgical (ISRG) optimistic about fourth-quarter and 2017 net sales outcome on revenue growth across all business segments.

                                        The Zacks Analyst Blog Highlights: Macy???s, Target, SS&C Technologies, Intuitive Surgical and Brighthouse Financial

                                        The Zacks Analyst Blog Highlights: Macy???s, Target, SS&C Technologies, Intuitive Surgical and Brighthouse Financial

                                          Abaxis' (ABAX) Preliminary Results for Q3 Cheer Investors

                                          Abaxis (ABAX) expects substantial tax savings from the recent U.S. tax reform.

                                            Hill-Rom (HRC) Estimates Strong Revenue Figures for Q1

                                            Hill-Rom (HRC) expects substantial tax savings from the recent U.S. tax reform.

                                              Benjamin Rains headshot

                                              Buy These 3 Stocks on Today's Strong Gains

                                              The New Year has been dominated by cryptocurrencies and blockchain technology, with unlikely companies such as Kodak (KODK) jumping on the bandwagon after announcing its new KODAKCoin and KODAKOne platform.

                                                NuVasive Q4 Preliminary Results Fail to Cheer Investors

                                                NuVasive (NUVA) continues to witness sequential growth in international revenues and expects substantial tax savings from the recent U.S. tax reform.

                                                  DexCom Estimates Strong Revenue Figures for Q4 and 2017

                                                  Dexcom (DXCM) to gain from strong sensor volumes, international revenues and expanding worldwide patient base in 2018.